Structure |
Chemical Name |
CAS |
MF |
|
Tafluprost Impurity 11 |
|
|
|
Tazobactam Impurity 4 |
|
|
|
Ticagrelor Impurity 103 |
|
|
|
Ticagrelor Impurity 94 |
|
|
|
Tofacitinib Impurity 119 |
|
|
|
Trelagliptin Impurity 26 |
|
|
|
Trelagliptin Impurity 31 |
|
|
|
Caspofungin impurity E |
|
|
|
Erythromycin Impurity C |
|
|
|
Itraconazole iMpurity 4 |
|
|
|
Azacitidine Impurity 3 |
|
|
|
Ozagrel Impurity 2 |
|
|
|
Olaparib Impurity 22 |
|
|
|
Irbesartan Impurity 14 |
133690-91-2 |
C25H28N6O |
|
Febuxostat Impurity 25 |
1643131-89-8 |
C17H20N2O4S |
|
Pregabalin Impurity 3 |
1928754-83-9 |
C12H22O3 |
|
Bosutinib Impurity 6 |
|
|
|
Ticagrelor Impurity 49 |
|
|
|
Edoxaban Impurity 14 |
|
|
|
Indacaterol Impurity 3 |
2250243-41-3 |
C26H32N2O3 |
|
Canagliflozin Impurity 11 |
|
|
|
Oseltamivir Impurity 22 |
|
|
|
Riociguat IMpurtiy B |
|
|
|
Silodosin Impurity C |
|
|
|
Dexmedetomidine-025 |
2250242-52-3 |
C20H22N2 |
|
pranoprofen impurity 15 |
|
|
|
Mono-Hydroxy Sugammadex |
2376607-99-5 |
C69H109NaO47S7 |
|
Metronidazole impurity A |
|
|
|
Sulpiride Impurity 6 |
|
|
|
Cefminox Impurity A |
|
|
|
Cefminox Impurity F |
|
|
|
(S-(R* S*))-(+)-N-(1-PHENYLETHYL)-1- AZ& |
120570-09-4 |
C15H24Cl2N2 |
|
CLOPIDOGREL RELATED COMPOUND B (20 MG) (METHYL(+/-)-(O-CHLOROPHENYL)-4,5-DIHYDROTHIE-NO[2,3-C]PYRIDINE-6(7H)-ACETATE, HYDROCHLORIDE) |
144750-52-7 |
C16H16ClNO2S.ClH |
|
VERAPAMIL RELATED COMPOUND B (50 MG) (AL-PHA-[2-[[2-(3,4-DIMETHOXYPHENYL)-ETHYL]METHYLA-MINO]ETHYL]-3,4-DIMETHOXY-ALPHA-(1-METHY-LETHYL)-BENZENEACETONITRILE MONOHYDROCHLORIDE) |
1794-55-4 |
C26H37ClN2O4 |
|
N-(5-(Propionyloxy)pentyl Acrylate) rac-trans-Laudanosine Benzenesulfonate |
155913-32-9 |
C38H49NO11S |
|
1,8-ditosyl-1,4,8,11-tetraazacyclotetradecane dihydrochloride |
|
C24H38Cl2N4O4S2 |
|
Mupirocin iMpurity 5 |
|
C26H44O9 |
|
Tolvaptan Impurity 11 |
150683-27-5 |
C25H23ClN2O3 |
|
1638785-19-9 |
1638785-19-9 |
C13H15ClO3 |
|
1155863-81-2 |
1155863-81-2 |
C23H19F2N3O6 |
|
1175018-73-1 |
1175018-73-1 |
C12H14ClN |
|
tert-butyl (3S,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- (phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate |
|
C37H43FN2O5 |
|
Clopidogrel Impurity 44 |
|
C15H14ClNO2S |
|
5-ethyl 7-methyl 6-(2-chlorophenyl)-8-methyl-3,4,5,6-tetrahydro-2H- benzo[b][1,4]oxazine-5,7-dicarboxylate |
949155-13-9 |
C20H22ClNO5 |
|
Nifedipine impurity 06 |
|
C19H22N2O6 |
|
Moxifloxacin Impurity 10 |
|
|
|
Ticagrelor Impurity 11 |
|
|
|
Parecoxib Impurity 18 |
|
|
|
Apixaban Impurity 34 |
|
|
|
Teneligliptin Impurity 9 DiHCl |
|
|
|
Pramipexole Impurity Z2 |
|
|
|
monocalciummono(4-(((2R,4R)-1-([1,1'-biphenyl]-4-yl)-5-ethoxy- 4-methyl-5-oxopentan-2-yl)amino)-4-oxobutanoate) |
|
C24H28CaNO5 |
|
Aprepitant iMpurity 40 |
|
|
|
Aprepitant iMpurity43 |
|
|
|
5-Vinylpyrrolidone |
7529-16-0 |
C6H9NO |
|
4-[N-(2,4-DIAMINO-6-PTERIDINYLMETHYL)-N-METHYLAMINO] BENZOIC ACID |
19741-14-1 |
C15H15N7O2 |
|
PROPYLENE GLYCOL MONOLAURATE |
27194-74-7 |
C15H30O3 |
|
ZOPICLONE N-OXIDE |
43200-96-0 |
C17H17ClN6O4 |
|
1-Propanamine, 3-(diphenylphosphinyl)-N,N-dimethyl- |
962-95-8 |
C17H22NOP |
|
Afatinib Impurity ODQ |
|
|
|
Afatinib Impurity QJJ |
2323570-72-3 |
C24H27ClFN5O4 |
|
Cabozantinib Impurity 50 |
202917-05-3 |
C17H14N2O5 |
|
Landiolol impurity U |
|
|
|
Teneligliptin Impurity 15 |
|
|
|
Nicergoline EP Impurity I |
|
|
|
Carbamic acid, N-[(4-methylphenyl)sulfonyl]- |
107628-27-3 |
C8H9NO4S |
|
9H-Purin-6-amine, 9-(2-chloropropyl)- |
50615-40-2 |
C8H10ClN5 |
|
Hyoscine Butylbromide EP Impurity G |
|
|
|
Cinacalcet Impurity 38 HCl |
938177-81-2 |
C21H24ClN |
|
Norepinephrine Impurity 23 |
1528622-09-4 |
C9H13NO3 |
|
Brexpiprazole Impurity 77 |
1783311-11-4 |
C12H14N2S |
|
(S)-1-(isopropylamino)-3-(4-(2-methoxyethyl)phenoxy)propan-2-ol |
114218-35-8 |
C15H26ClNO3 |
|
Recombinant Endo Beta-N-Acetylglucosaminidase (ENGASE) |
|
|
|
1-Pentanone, 1-(2-hydroxy-5-methylphenyl)- |
150033-77-5 |
C12H16O2 |
|
3-methyl-2-pentylphenol |
1823068-39-8 |
C12H18O |
|
PLSQ-001 TM4-QJ |
1227162-74-4 |
C18H24N2O2 |
|
(2S)-2-(2,5-dioxo-3-propylpyrrolidin-1-yl)butanoic acid |
2101641-92-1 |
C11H17NO4 |
|
2-Pyridineethanamine, N-methyl-N-[2-(2-pyridinyl)ethyl]-, hydrochloride (1:3) |
2095467-43-7 |
C15H20ClN3 |
|
(S)-tert-butyl (1-(3-(2-cyanobenzyl) |
1618644-31-7 |
C23H29N5O4 |
|
Droxidopa Impurity 4 |
55382-14-4 |
C31H29NO7 |
|
(1r,4r)-4-(5,6-dibromo-2-methylquinazolin-3(4H)-yl)cyclohexan-1-ol |
|
|
|
Dapagliflozin Impurity (MW:423Da) |
|
|
|
Ramipril - Isomer Impurity 1 |
|
|
|
Aripiprazole peroxide degradation Impurity (MW:480Da) |
|
|
|
Fosinopril Sodium Impurity A (Fosinoprilat) |
|
|
|
Dapoxetine Impurity 40 |
|
|
|
Doxofylline Impurity 15 |
|
|
|
Iohexol Impurity 10 |
|
|
|
Salbutamol Impurity 40 |
|
|
|
Benzylpenicillin EP(CP) Impurity F |
|
|
|
(3R,5R)-7-(2-(2-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid |
2243639-98-5 |
C33H37CaFN2O5 |
|
Flucloxacillin sodium EP Impurity A |
|
|
|
Nilotinib Impurity 28 |
1807607-72-2 |
C28H20F3N7O3 |
|
T-IRR |
|
|
|
Escitalopram Acid Impurity |
1133881-04-5 |
C20H22FNO3 |
|
1,3,6,10,14-Hexadecapentaene, 3,7,11,15-tetramethyl-, (3E,6E,10E)- |
77898-97-6 |
C20H32 |
|
BROMOCRIPTINE IMPURITY A |
|
C32H40BrN5O5 |
|
(1'R,3'S,3S,5R,6R)-5-AMINO-2-AMINOMETHYL-6-(4,6-DIAMINO-2,3-DIHYDROXY-CYCLOHEXYLOXY)-TETRAHYDRO-PYRAN-3,4-DIOL |
3947-65-7 |
C12H26N4O6 |
|
1-ETHYL-1-METHYLSUCCINIC ACID |
631-31-2 |
C7H12O4 |
|
MUPIROCIN CALCIUM, REFERENCE SPECTRUM EP STANDARD |
115074-43-6 |
C52H86CaO18.2H2O |